Other News To Note
Tuesday, February 5, 2013
Bionomics Ltd., of Adelaide, Australia, presented new data on BNC375, its drug candidate with potential for the treatment of memory loss in Alzheimer's disease, at the 33rd Annual Meeting of the Australian Neuroscience Society in Melbourne, Australia.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.